Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Does CIN2 Have the Same Aggressive Potential As CIN3? A Secondary Analysis of High-Grade Cytology Recurrence in Women Treated with Cold-Coagulation Cervical Treatment.

Papoutsis D, Underwood M, Parry-Smith W, Panikkar J.

Geburtshilfe Frauenheilkd. 2017 Mar;77(3):284-289. doi: 10.1055/s-0042-119993.

2.
3.

Knowledge about Cervical Cancer and Associated Factors among 15-49 Year Old Women in Dessie Town, Northeast Ethiopia.

Mitiku I, Tefera F.

PLoS One. 2016 Sep 30;11(9):e0163136. doi: 10.1371/journal.pone.0163136. eCollection 2016.

4.

Preventable fractions of cervical cancer via effective screening in six Baltic, central, and eastern European countries 2017-40: a population-based study.

Vaccarella S, Franceschi S, Zaridze D, Poljak M, Veerus P, Plummer M, Bray F.

Lancet Oncol. 2016 Oct;17(10):1445-1452. doi: 10.1016/S1470-2045(16)30275-3. Epub 2016 Aug 23.

5.

Cervical and anal HPV infection: cytological and histological abnormalities in HIV-infected women in Thailand.

Ramautarsing RA, Phanuphak N, Chaithongwongwatthana S, Wit FW, Teeratakulpisarn N, Pankam T, Rodbamrung P, Wijgert JH, Lange JM, Phanuphak P, Sahasrabuddhe VV, Kerr S, Ananworanich J.

J Virus Erad. 2015 Apr 1;1(2):96-102.

6.

Does the vaginal microbiota play a role in the development of cervical cancer?

Kyrgiou M, Mitra A, Moscicki AB.

Transl Res. 2017 Jan;179:168-182. doi: 10.1016/j.trsl.2016.07.004. Epub 2016 Jul 15. Review.

PMID:
27477083
7.

Cost-Effectiveness of Different Cervical Screening Strategies in Islamic Republic of Iran: A Middle-Income Country with a Low Incidence Rate of Cervical Cancer.

Nahvijou A, Daroudi R, Tahmasebi M, Amouzegar Hashemi F, Rezaei Hemami M, Akbari Sari A, Barati Marenani A, Zendehdel K.

PLoS One. 2016 Jun 8;11(6):e0156705. doi: 10.1371/journal.pone.0156705. eCollection 2016.

8.

Experiences of cervical screening and barriers to participation in the context of an organised programme: a systematic review and thematic synthesis.

Chorley AJ, Marlow LA, Forster AS, Haddrell JB, Waller J.

Psychooncology. 2017 Feb;26(2):161-172. doi: 10.1002/pon.4126. Epub 2016 Apr 12. Review.

9.

Electrical Bioimpedance Analysis: A New Method in Cervical Cancer Screening.

Das L, Das S, Chatterjee J.

J Med Eng. 2015;2015:636075. doi: 10.1155/2015/636075. Epub 2015 Feb 2.

10.

Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3.

Boers A, Wang R, van Leeuwen RW, Klip HG, de Bock GH, Hollema H, van Criekinge W, de Meyer T, Denil S, van der Zee AGJ, Schuuring E, Wisman GBA.

Clin Epigenetics. 2016 Mar 9;8:29. doi: 10.1186/s13148-016-0196-3. eCollection 2016.

11.

The Value of In Vitro Diagnostic Testing in Medical Practice: A Status Report.

Rohr UP, Binder C, Dieterle T, Giusti F, Messina CG, Toerien E, Moch H, Schäfer HH.

PLoS One. 2016 Mar 4;11(3):e0149856. doi: 10.1371/journal.pone.0149856. eCollection 2016. Erratum in: PLoS One. 2016;11(4):e0154008.

12.

HPV immunisation and cervical screening--confirmation of changed performance of cytology as a screening test in immunised women: a retrospective population-based cohort study.

Palmer TJ, McFadden M, Pollock KG, Kavanagh K, Cuschieri K, Cruickshank M, Cotton S, Nicoll S, Robertson C.

Br J Cancer. 2016 Mar 1;114(5):582-9. doi: 10.1038/bjc.2015.474. Epub 2016 Feb 4.

13.

Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women.

De Strooper LM, Verhoef VM, Berkhof J, Hesselink AT, de Bruin HM, van Kemenade FJ, Bosgraaf RP, Bekkers RL, Massuger LF, Melchers WJ, Steenbergen RD, Snijders PJ, Meijer CJ, Heideman DA.

Gynecol Oncol. 2016 May;141(2):341-7. doi: 10.1016/j.ygyno.2016.02.012. Epub 2016 Mar 3.

14.

Influence of Spirituality and Modesty on Acceptance of Self-Sampling for Cervical Cancer Screening.

Dareng EO, Jedy-Agba E, Bamisaye P, Isa Modibbo F, Oyeneyin LO, Adewole AS, Olaniyan OB, Dakum PS, Pharoah PD, Adebamowo CA.

PLoS One. 2015 Nov 3;10(11):e0141679. doi: 10.1371/journal.pone.0141679. eCollection 2015.

15.

Soil-Transmitted Helminth Infections Are Associated With an Increase in Human Papillomavirus Prevalence and a T-Helper Type 2 Cytokine Signature in Cervical Fluids.

Gravitt PE, Marks M, Kosek M, Huang C, Cabrera L, Olortegui MP, Medrano AM, Trigoso DR, Qureshi S, Bardales GS, Manrique-Hinojosa J, Cardenas AZ, Larraondo MA, Cok J, Qeadan F, Siracusa M, Gilman RH.

J Infect Dis. 2016 Mar 1;213(5):723-30. doi: 10.1093/infdis/jiv498. Epub 2015 Oct 20.

16.

The impact of HPV vaccination on future cervical screening: a simulation study of two birth cohorts in Denmark.

Hestbech MS, Lynge E, Kragstrup J, Siersma V, Vazquez-Prada Baillet M, Brodersen J.

BMJ Open. 2015 Aug 14;5(8):e007921. doi: 10.1136/bmjopen-2015-007921.

17.

p16(INK4a)/Ki-67 dual stain cytology for cervical cancer screening in Thika district, Kenya.

Ngugi CW, Schmidt D, Wanyoro K, Boga H, Wanzala P, Muigai A, Mbithi J, von Knebel Doeberitz M, Reuschenbach M.

Infect Agent Cancer. 2015 Aug 11;10:25. doi: 10.1186/s13027-015-0020-2. eCollection 2015.

18.

Impact of opportunistic testing in a systematic cervical cancer screening program: a nationwide registry study.

Tranberg M, Larsen MB, Mikkelsen EM, Svanholm H, Andersen B.

BMC Public Health. 2015 Jul 21;15:681. doi: 10.1186/s12889-015-2039-0. Erratum in: BMC Public Health. 2015;15:893.

19.

Prevalence and risk factors for cancer of the uterine cervix among women living in Kinshasa, the Democratic Republic of the Congo: a cross-sectional study.

Ali-Risasi C, Verdonck K, Padalko E, Vanden Broeck D, Praet M.

Infect Agent Cancer. 2015 Jul 15;10:20. doi: 10.1186/s13027-015-0015-z. eCollection 2015.

20.

Understanding cervical screening non-attendance among ethnic minority women in England.

Marlow LA, Wardle J, Waller J.

Br J Cancer. 2015 Sep 1;113(5):833-9. doi: 10.1038/bjc.2015.248. Epub 2015 Jul 14.

Supplemental Content

Support Center